Buy XPOF by Jan 5, 2027.

I’ve been watching **Xponential Fitness (XPOF)** pretty closely over the last several sessions, including price action, Level 2, time & sales, FINRA/off-exchange prints, volume, short interest, moving averages, MACD, RSI, and options positioning. I’m not posting this as a “MOASS tomorrow” prediction. There are some legitimate bullish ingredients here, but there are also several things XPOF still has to prove. Here’s what I’m seeing. **The short-interest setup is legitimate** The most recent data we reviewed showed roughly: **10.31 million shares …